Improved downstream operation through formulation innovation
Lead Participant:
ARECOR LIMITED
Abstract
The aim of this project is to provide new formulations that bring about a step change in biopharmaceutical yield and quality by improving product stability through the most protein degradation sensitive/impactful areas of downstream processing (DSP). This is a novel approach to improving process efficiency as currently protein products have comparatively limited stability in the existing default DSP buffers. To develop a new platform of formulations and formulation strategies this collaborative project will bring together the formulation expertise of Arecor with the DSP expertise at Fujifilm Diosynth Biotechnologies (FDB) and The Centre for Process Innovation (CPI). The platform of formulations and the formulations strategies developed can then be applied to reduce production cost of all biologics to pharma and ultimately cost to healthcare providers. These new formulations may also enable the production of biotherapeutics that are currently very difficult/impossible to manufacture.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
ARECOR LIMITED | £895,705 | £ 537,423 |
  | ||
Participant |
||
CENTRE FOR PROCESS INNOVATION LIMITED | £947,412 | £ 947,412 |
CPI INNOVATION SERVICES LIMITED | ||
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED | £147,476 | £ 73,738 |
INNOVATE UK |
People |
ORCID iD |
Hanane Cherif (Project Manager) |